Media
Careers
Investors
About
Leadership Team
Board of Directors
Advisory Board
Clinical Trials
About TIGeR-PaC
TIGeR-PaC
Candidate Criteria
TIGeR-PaC Participating
Clinical Sites
Our Therapy Platform
Pipeline Overview
Clinicians
Contact
About
Leadership Team
Board of Directors
Advisory Board
Clinical Trials
About TIGeR-PaC
TIGeR-PaC
Candidate Criteria
TIGeR-PaC Participating
Clinical Sites
Our Therapy Platform
Pipeline Overview
Clinicians
News
Careers
Investors
Contact
Investors
Investors
Overview
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
News & Events
Overview
Press Releases
Clinical News
IR Calendar Events
Email Alerts
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Press Releases
Year
All Years
2024
2023
2022
2021
2020
2018
2017
2016
2015
2014
2013
Category
All Releases
Financial Releases
Nov 19, 2015 11:42am EST
RenovoRx Joins Stanford-Backed StartX Med Program
Oct 20, 2015 12:00pm EDT
RenovoRx Receives CE Mark for RenovoCath™
Jun 03, 2015 11:30am EDT
First Patient Enrolled in Study Using the RenovoCath™
May 07, 2015 1:56pm EDT
El Camino Hospital Performs First In-Human Use of RenovoCath™ Catheter
Oct 30, 2014 11:00am EDT
RenovoCath™ RC120 Catheter Receives FDA Clearance
Oct 28, 2014 11:00am EDT
RenovoRx Announces the U.S. Patent and Trademark Office Issuance of Patent
Oct 27, 2014 11:00am EDT
RenovoRx Board Names Shaun R. Bagai as CEO
Jan 27, 2014 3:00pm EST
RenovoRx Announces Closing of a $1.15 million Series B Financing
May 21, 2013 2:41pm EDT
RenovoRx Named Winner of 2013 TiE50 "Top Startup"
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
rss_feed
News RSS
Email Alerts
Contacts
RSS News Feed
Menu